Familial hyperlipoproteinemia type IIA with homozygotic manifestations in a heterozygote
Traurig, J.; Sobra, J.; Kvasilová, M.; Wildtová, Z.
Vnitrni Lekarstvi 24(7): 684-690
1978
ISSN/ISBN: 0042-773X PMID: 209627 Document Number: 138198
Document emailed within 1 workday
Related Documents
Matsuura, F. 2007: Familial hyperlipoproteinemia, type IV Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 326-328Di Gruttola, G.; Ferrara, M. 1977: Familial congenital type IIB hyperlipoproteinemia La Pediatria 85(3): 435-442
Andersen, G.E.; Friis-Hansen, B. 1976: Neonatal diagnosis of familial type Ii hyperlipoproteinemia Pediatrics 57(2): 214-220
Arranz Peña, M.L.; Alonso de la Peña, M.C. 1985: Hyperlipoproteinemia type I. Study of a familial deficiency of lipoprotein-lipase Revista Clinica Espanola 176(2): 98-100
Kuŝić, M.; Gavrilović, M.; Mihajloviĉ, M.; Boŝković, B. 1980: Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol Srpski Arhiv Za Celokupno Lekarstvo 108(9): 875-881
Koffigan, M.; Fruchart, J.C.; Dhondt, J.L.; Moschetto, Y.; Farriaux, J.P. 1982: Apolipoprotein B measurement in blood spotted on paper (a screening test for familial type II A hyperlipoproteinemia) La Ricerca in Clinica E in Laboratorio 12(1): 169-172
Jansen, S.; Zambrana, J.L.; López Miranda, J.; Blanco, A.; Blanco, J.; Jiménez Perepérez, J.A.; Espino, A.; Pérez Jiménez, F. 1995: Possible relationship between overweightness and prevalence of hyperlipemia in the children of patients with heterozygote familial hypercholesterolemia and combined familial hyperlipemia Medicina Clinica 105(3): 85-88
Chen, K.; Mu, Y.-m.; Wang, B.-a.; Guo, Q.-h.; Lü, Z.-h.; Dou, J.-t.; Lu, J.-m. 2006: A compound heterozygote family of familial hypercholesterolemia due to new mutations Zhonghua Nei Ke Za Zhi 45(9): 725-729
Riesen, W.F.; Descoeudres, C.; Mordasini, R.; Girod, M.A. 1989: Selective elimination of atherogenic lipoproteins using dextran-sulfate cellulose. Experiences in 2 patients with heterozygote familial hypercholesterolemia Schweizerische Medizinische Wochenschrift 119(2): 55-58
De Gennes, J.L. 1988: Genetic studies in familial hyperlipoproteinemia, and therapeutic implications Annales de Biologie Clinique 46(1): 1-3
Arntz, H.R.; Klemens, U.H.; Vollmar, L.J.; Lang, P.D. 1978: Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia Medizinische Klinik 73(49): 1731-1737
Bolzano, K.; Krempler, F.; Schellenberg, B.; Schlierf, G. 1979: A comparison of bezafibrate and clofibrate in type Ii B and type IV hyperlipoproteinemia Acta Medica Austriaca 6(3): 90-94
Syc, S.; Kujawski, J. 1973: Case of acute renal failure during pancreatitis in a patient with familial hyperlipoproteinemia Wiadomosci Lekarskie 26(3): 243-245
Kantorová, E. 1990: Risk factors in persons with early manifestations of ischemic heart disease and in their offspring. I. Hyperlipoproteinemia Casopis Lekaru Ceskych 129(39): 1224-1227
Jayo, A.; Pabón, D.; Lastres, P.; Jiménez-Yuste, V.; González-Manchón, C. 2006: Type II Glanzmann thrombasthenia in a compound heterozygote for the alpha IIb gene. A novel missense mutation in exon 27 Haematologica 91(10): 1352-1359
Heckers, H.; Oehler, G. 1975: Type-V-hyperlipoproteinemia Die Medizinische Welt 26(39): 1766-1774
Calderín, F.M.; Perianes, J.; Nuño, J.; De Oya, M. 1977: Hyperlipoproteinemia type i Revista Clinica Espanola 147(1): 81-84
Bustos, P.; Fernández, E.; Radrigán, E. 1987: Hyperlipoproteinemia type i Revista Chilena de Pediatria 58(6): 481-484
Wu, Y.S.; Wang, Y.; Huang, C.H.; Lan, F.H.; Zhu, Z.Y. 2000: A compound heterozygote in the NADH-cytochrome b5 reductase gene from a Chinese patient with hereditary methemoglobinemia type I International Journal of Hematology 72(1): 34-36
Benöhr, H.C.; Usener, H.; Wagner, H.; Kleinhauer, E.; Waller, H.D. 1970: Spontaneous hemolysis in a patient with glucose-6-p-dehydrogenase deficiency (Mediterranean type) and heterozygote beta thalassemia Die Medizinische Welt 24: 1091-1095